Axogen Inc. (NASDAQ: AXGN) develops and markets technologies for peripheral nerve repair, offering solutions that restore function and quality of life for patients with nerve injuries. Its portfolio includes nerve grafts, connectors, and wraps that support surgeons in reconstructive and trauma procedures. Axogen’s shares move with surgical adoption rates, reimbursement developments, and clinical results supporting broader use of its products.